Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (221-230 of 405) with videos related to

Pageof 41
Sort By:
Cardiology|October 5, 2006
Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionDan Atar, Kurt Huber, Hans-Jürgen Rupprecht, et al.
Circulation. Heart Failure|November 2, 2014
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophyThomas G von Lueder, Bing H Wang, Andrew R Kompa, et al.
European Heart Journal|October 27, 2009
Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classificationsVictor Serebruany, Sunil V Rao, Matthew A Silva, et al.
Cardiovascular Drugs and Therapy|August 24, 2022
A Comprehensive Review of the Pleiotropic Effects of TicagrelorJeffrey Triska, Neil Maitra, Matthew R Deshotels, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 8, 2018
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting SystemVictor L Serebruany, Trygve S Hall, Dan Atar, et al.
Journal of Electrocardiology|September 18, 2017
Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudyMaria Sejersten, Yama Fakhri, Marianne Pape, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 8, 2018
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysisMagnus Dahl Aarvik, Irene Sandven, Tatendashe B Dondo, et al.
Circulation. Heart Failure|May 23, 2013
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failureThomas G von Lueder, S Jeson Sangaralingham, Bing H Wang, et al.
Journal of Thrombosis and Thrombolysis|January 12, 2008
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-studyLouis T van Zyl, Francois Lespérance, Nancy Frasure-Smith, et al.
International Journal of Cardiology|April 2, 2015
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesisBing H Wang, Thomas G von Lueder, Andrew R Kompa, et al.
Pageof 41

Showing results (221-230 of 405) with videos related to

Sort By:
Pageof 41
Cardiology|October 5, 2006
Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionDan Atar, Kurt Huber, Hans-Jürgen Rupprecht, et al.
Circulation. Heart Failure|November 2, 2014
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophyThomas G von Lueder, Bing H Wang, Andrew R Kompa, et al.
European Heart Journal|October 27, 2009
Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classificationsVictor Serebruany, Sunil V Rao, Matthew A Silva, et al.
Cardiovascular Drugs and Therapy|August 24, 2022
A Comprehensive Review of the Pleiotropic Effects of TicagrelorJeffrey Triska, Neil Maitra, Matthew R Deshotels, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 8, 2018
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting SystemVictor L Serebruany, Trygve S Hall, Dan Atar, et al.
Journal of Electrocardiology|September 18, 2017
Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudyMaria Sejersten, Yama Fakhri, Marianne Pape, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 8, 2018
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysisMagnus Dahl Aarvik, Irene Sandven, Tatendashe B Dondo, et al.
Circulation. Heart Failure|May 23, 2013
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failureThomas G von Lueder, S Jeson Sangaralingham, Bing H Wang, et al.
Journal of Thrombosis and Thrombolysis|January 12, 2008
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-studyLouis T van Zyl, Francois Lespérance, Nancy Frasure-Smith, et al.
International Journal of Cardiology|April 2, 2015
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesisBing H Wang, Thomas G von Lueder, Andrew R Kompa, et al.
Pageof 41